Insights

End to End LatchBio provides an end to end bioinformatics platform and is expanding it with Pods, a GPU enabled cloud portal that lets researchers write, run, and share notebook code. This enables customers to manage data, run analyses, and collaborate in one ecosystem with reduced procurement friction. This combination creates a compelling upsell for pharma, biotech, and academic teams seeking integrated compute, data management, and collaboration capabilities.

Spatial Atlas LatchBio is launching a large scale spatial transcriptomics data product (cell atlas) that integrates multiple tissue types, diseases and technologies. The offering supports new data led workflows and collaborations for translational researchers and CROs. There is a clear opportunity to license or bundle access to this data with the platform to accelerate spatial omics projects.

GPU Compute Pods targets researchers needing accessible GPU compute and reproducible workflows, a common bottleneck in genomics and methylation analyses. The product opens a path to upsell high throughput analytics, training, and collaborative notebooks across distributed teams. Marketing angles include proven performance on GPU hardware and streamlined notebook sharing across organizations.

Global Lab Network With a global base serving pharma, biotech and academic teams, LatchBio has a broad market footprint for expansion into enterprise level contracts and multi site deployments. The breadth enables cross sell of new data products and compute services to existing customers and potential channel partners. The diversified customer mix supports risk balanced growth and repeatable revenue.

Growth Momentum Substantial funding activity and a growing revenue footprint indicate market validation and scale potential. The company is rapidly expanding its product capabilities and attracting external investment, creating credibility for partner programs and joint go to market strategies. Engage potential customers with a clear roadmap and ecosystem partnerships to accelerate onboarding.

LatchBio Tech Stack

LatchBio uses 8 technology products and services including DoubleClick Floodlight, html5media, Amazon Web Services, and more. Explore LatchBio's tech stack below.

  • DoubleClick Floodlight
    Advertising
  • html5media
    Audio, Video, Graphics
  • Amazon Web Services
    Cloud Hosting
  • Cloudflare CDN
    Content Delivery Network
  • Vite
    Miscellaneous
  • Rust
    Programming Languages
  • Cloudflare Bot Management
    Security
  • Radix UI
    UI Frameworks

Media & News

LatchBio's Email Address Formats

LatchBio uses at least 1 format(s):
LatchBio Email FormatsExamplePercentage
First@latch.bioJohn@latch.bio
88%
Last@latch.bioDoe@latch.bio
8%
First.Last@latch.bioJohn.Doe@latch.bio
4%

Frequently Asked Questions

What is LatchBio's official website and social media links?

Minus sign iconPlus sign icon
LatchBio's official website is latch.bio and has social profiles on LinkedInCrunchbase.

What is LatchBio's SIC code NAICS code?

Minus sign iconPlus sign icon
LatchBio's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does LatchBio have currently?

Minus sign iconPlus sign icon
As of July 2026, LatchBio has approximately 36 employees across 2 continents, including North AmericaAsia. Key team members include Product Designer: N. M.. Explore LatchBio's employee directory with LeadIQ.

What industry does LatchBio belong to?

Minus sign iconPlus sign icon
LatchBio operates in the Biotechnology Research industry.

What technology does LatchBio use?

Minus sign iconPlus sign icon
LatchBio's tech stack includes DoubleClick Floodlighthtml5mediaAmazon Web ServicesCloudflare CDNViteRustCloudflare Bot ManagementRadix UI.

What is LatchBio's email format?

Minus sign iconPlus sign icon
LatchBio's email format typically follows the pattern of First@latch.bio. Find more LatchBio email formats with LeadIQ.

How much funding has LatchBio raised to date?

Minus sign iconPlus sign icon
As of July 2026, LatchBio has raised $28M in funding. for $28M.

When was LatchBio founded?

Minus sign iconPlus sign icon
LatchBio was founded in 2021.
LatchBio logo

LatchBio

Biotechnology ResearchCalifornia, United States11-50 Employees

LatchBio operates in the biotechnology research sector, providing an integrated infrastructure for biology that bundles kits and machines. The company serves a global roster of pharma, biotech, and academic teams, enabling researchers to access integrated tools and workflows. It is based in San Francisco, California. In September 2025, LatchBio announced the launch of a 25-million-cell atlas for spatial transcriptomics, spanning 45 tissue types, 63 diseases, and 11 spatial technologies. The firm operates within biotechnology research and positions itself as a provider of essential infrastructure to support scientific work.

Section iconCompany Overview

Website
latch.bio
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2021
Employees
11-50

Section iconFunding & Financials

  • $28M

    LatchBio has raised a total of $28M of funding over 4 rounds. in the amount of $28M.

  • $10M$25M

    LatchBio's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $28M

    LatchBio has raised a total of $28M of funding over 4 rounds. in the amount of $28M.

  • $10M$25M

    LatchBio's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.